Carl J. Accettura has the credentials and experience to help you get to where you want to go.

Carl founded Global Pharma Consulting in 2004 to provide Rx commercialization services expertise to emergent pharmaceutical firms. Japanese companies have embraced Carl’s virtual model. He prepared Kyowa Pharmaceuticals for commercialization of a novel therapy for Parkinsons Disease while running his own firm. Carl then commercialized Latuda ®, a novel schizophrenia drug for Dainippon Sumitomo Pharma America, which is now Sunovion Pharmaceuticals.

Carl is a veteran of FDA regulated operations, with nearly 30 years of diversified global experience in both large and small pharmaceutical firms. He has made senior management level contributions in the areas of global drug commercialization, global supply chain management, project management and drug development.

Over the past year, Carl consulted with and joined the senior leadership team at Braeburn Pharmaceuticals to commercialize Probuphine®, a breakthrough therapy for opioid addiction. Braeburn is part of Apple Tree Partners, which creates and owns complementary life sciences businesses (pharmaceuticals, medical devices, and technology-enabled healthcare services).

From 1998 to 2001, Carl was a Corporate Officer and Vice President of Operations at Anesta Pharmaceutical in Salt Lake City with responsibilities for worldwide clinical & commercial manufacturing, tech transfer, validation, CMC filings and regulatory inspection & approval by UK MHRA and US FDA. Carl helped to successfully commercialize Actiq for cancer pain in the US, EU, and globally. Actiq reached $700 million in sales for treatment of breakthrough cancer pain.

Previously, in “Big Pharma”, Carl was Vice President, Worldwide Supply Chain Management, Bristol-Myers Squibb ConvaTec and Vice President, Materials Management, Hoffman-La Roche. His background also includes Director level positions at Pfizer Pharmaceuticals in new product planning, strategic planning and pharmaceutical systems. He began his career as a Merck Design Engineer.

Mr. Accettura holds a BS degree in Mechanical Engineering from Cornell University (Class of ’75), an MS degree in Mechanical Engineering from the University of Illinois, and an MBA degree from New York University. He has served on the Advisory Board of the Cornell University Center for Manufacturing Enterprise and the LogiPharma Advisory Board. Carl has been a frequent speaker at the Cornell Engineering Enterprise Seminar, since 1990. Carl has been active professionally in PMA, ISPE, PDA, IVT, ASQ, and APICS.